Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Broad Center for Mendelian Genomics, |
RCV000143862 | SCV000786709 | pathogenic | Cone-rod dystrophy 20 | criteria provided, single submitter | research | The homozgous p.Arg106Pro variant was identified by our study in one individual with cone-rod dystrophy. The p.Arg106Pro is pathogenic due to evidence in the literature. This variant has been reported to be homozygous in 8 individuals with either cone dystrophy or cone-rod dystrophy across 3 families. | |
Labcorp Genetics |
RCV001857487 | SCV002235703 | pathogenic | not provided | 2022-08-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects POC1B function (PMID: 25018096). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 155769). This missense change has been observed in individuals with autosomal recessive cone-rod dystrophy (PMID: 24945461, 25018096). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 106 of the POC1B protein (p.Arg106Pro). |
OMIM | RCV000143862 | SCV000188730 | pathogenic | Cone-rod dystrophy 20 | 2014-10-01 | no assertion criteria provided | literature only |